ThermoGenesis Holdings, Inc. KOOL Cash Flow

Thermogenesis holdings, inc. (KOOL)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
Cash flows from operating activities:
Net loss
-12,795	-10,099	-13,190	-13,580	-39,617	-40,940	-33,828	-33,651	-7,294	-6,021	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-9,237	-	0	0	-37,636	-	-17,268	-11,206	-14,953	-14,852	-15,348	-12,396	-9,628	-8,631	-8,158	-7,420	-6,380	-3,086	-1,427	-2,068	-2,783	-4,986	-5,416	-4,499	-3,707	-2,567	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
798	805	768	739	717	670	668	655	653	679	729	830	950	982	1,064	1,168	1,214	1,343	1,394	1,351	1,419	1,333	1,159	993	725	599	560	538	616	668	639	604	492	420	437	466	0	0	0
Stock-based compensation expense
600	614	636	558	596	652	634	591	609	719	1,295	1,461	1,471	1,471	697	742	832	875	1,306	1,247	1,183	1,071	794	679	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount/premium, net
2,285	2,349	0	0	0	-	-	-	-	-	-160	9,851	10,789	16,076	16,123	6,127	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of accelerated debt discount due to conversion
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reserve for excess and slow-moving inventories
12	92	256	366	104	-11	-315	-414	-357	-306	-105	-203	78	196	354	566	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reserve for bad debt expense
0	-	-	-	0	-	-	-	-	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and issue costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative obligation
-	-	-	-	-	596	737	700	436	246	252	-61	138	-385	1,643	3,395	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash accrued interest
-	-	-	-	-	-	-	-	-	-	0	10,373	11,404	11,404	11,404	1,031	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of equipment
-	-	-	-	-	-	-	-	-	-184	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	850	974	1,144	960	0	0	0
Gain on sale of product lines
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,161	2,161	2,000	2,000	0	0	0	0	-	-	-	-
Net change in operating assets and liabilities:
Accounts receivable
-34	-301	2,406	1,406	336	-1,045	-1,272	-1,856	-1,137	-316	419	522	-1,133	-464	-645	-1,949	-1,608	-1,061	-681	459	-212	-1,269	-145	-515	680	183	694	340	168	434	-835	655	370	-273	-1,331	-2,132	0	0	0
Inventories
-111	-610	-705	-868	-384	-61	116	725	576	563	-442	-615	-407	-929	-180	-375	-928	-354	-1,039	-254	955	1,129	1,449	1,279	629	-92	-620	-795	-1,094	-1,152	-363	-120	284	1,038	1,599	1,338	0	0	0
Prepaid expenses and other assets
105	525	161	52	-241	-370	-5	90	213	310	67	-24	-144	-200	72	86	264	162	-357	-54	3	115	123	-64	-190	-284	-47	-106	227	250	171	38	-4	-51	-107	-1	0	0	0
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	4	12	9	0	0	0	-	-	-	-	-1	-216	-80	-141	-119	0	0	0
Accounts payable
31	-966	79	1,205	183	214	-384	227	213	-6	216	-1,062	-1,424	-2,381	-3,552	-2,420	-1,433	1,188	2,281	1,410	1,212	-330	-978	-295	1,293	1,337	1,713	619	-506	-248	-315	696	24	-366	-589	-592	0	0	0
Interest payable – related party
0	-	-	-	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued payroll and related expenses
-65	-415	21	-95	32	172	-43	198	136	-1,087	58	-63	-15	1,159	-247	-256	-662	-499	150	105	305	403	-165	96	61	92	26	-130	-257	15	55	223	365	162	136	75	0	0	0
Deferred revenue – short term
-146	135	312	-138	43	24	-153	41	-46	-19	43	-187	140	103	58	148	-96	-158	-22	-3	159	101	-26	282	133	88	161	-47	-120	-165	-93	2	7	-56	-148	-604	0	0	0
Other current liabilities
1,151	1,143	463	82	687	922	848	698	963	440	95	26	-308	-605	-595	160	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term deferred revenue and other noncurrent liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other noncurrent liabilities
-	-	-	-	-	-	-	40	46	83	97	97	-243	101	94	64	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	886	828	546	152	-416	-405	-356	-128	-536	-417	-257	-660	-338	-759	-1,150	-822	0	0	0
Net cash used in operating activities
-3,365	-3,260	-3,070	-3,792	-7,356	-6,983	-9,298	-9,419	-7,482	-7,962	0	0	0	-	0	-	-	-	-	-10,649	0	0	0	-	-	-	-	-3,082	-3,118	-3,281	-3,142	-3,885	-4,371	-4,673	-3,093	-2,092	0	0	0
Cash flows from investing activities:
Cash paid for business acquisition
-	-	-	-	-	-	-	-	-	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital expenditures
167	182	431	530	986	1,238	1,141	1,146	652	395	361	375	417	384	677	710	645	734	435	587	620	704	612	402	375	230	225	391	353	378	804	545	644	712	284	266	0	0	0
Net cash provided by (used in) investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of product lines
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,535	2,535	2,000	2,000	0	0	0	0	-	-	-	-
Net cash used in investing activities:
-167	-182	-431	-530	-986	-1,238	-1,141	-2,146	-1,652	-1,395	0	0	0	-	0	-	-	-	-	-	-	0	0	-	-	-	-	2,144	2,182	2,122	1,196	-545	-644	-712	-267	-249	0	0	0
Cash flows from financing activities:
Proceeds from convertible promissory note-related party
1,869	1,513	0	0	0	-	-	-	5,700	6,700	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment on finance lease obligations
30	24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of financing cost
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on capital lease obligations
-	-	-	-	-	-	-	-	-	53	64	70	90	86	76	67	67	71	74	60	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	2	0	0	0
Proceeds from issuance of common stock, net of expenses
0	-	-	-	-	6,629	9,023	8,400	3,581	2,368	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of options, warrants and pre-funded warrants
206	154	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for taxes on vested restricted stock
-	-	-	-	-	-	-	-	-	-	52	-	0	0	137	-	37	54	79	129	97	80	55	68	71	71	71	57	54	54	54	0	0	0	0	-	-	-	-
Proceeds from note payable
-	1,800	0	0	0	-	-	-	-	-	-	-	-	-	-	18,000	18,000	4,720	4,720	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net
-	-	-	-	-	-	-	-	-	-	1	-	0	0	4,554	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
7,021	4,199	4,080	3,675	7,709	7,111	11,198	12,015	9,214	8,965	0	0	0	-	0	-	-	-	-	-189	0	0	0	-	-	-	-	-57	-54	-54	-54	0	-19	3,913	3,920	3,919	0	0	0
Effects of foreign currency rate changes on cash and cash equivalents
0	-	-	-	-	-3	-3	-2	1	6	2	4	0	0	-2	-	-12	-2	-18	-29	-32	-27	-11	7	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Effects of foreign currency rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash, cash equivalents and restricted cash
3,482	757	580	-647	-635	-1,113	756	448	81	-386	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of cash flow information:
Cash paid for interest
613	177	1,616	1,678	2,178	667	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-3,144	-	0	0	-951	-	2,455	-5,415	-4,155	-11,454	-1,783	6,027	5,408	7,927	-946	-5,186	-3,447	-995	-990	-1,213	-2,000	-4,430	-5,034	-1,472	560	1,578	0	0	0
Supplemental non-cash financing and investing information:
Recording of beneficial conversion feature on debt
2,669	2,313	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-to-use asset acquired under operating lease
-	966	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Subsidiary common stock issued for acquisition of net assets
-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer of equipment to inventories
-	-	-	-	-	172	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for payment of convertible debenture and interest
-	-	-	-	-	-	-	-	-	-	-2	23,903	23,905	23,905	23,905	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Derivative obligation related to issuance of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,282	4,282	4,282	4,282	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer of inventories to equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	834	561	214	59	0	0	0	0	-	-	-	-
Equipment acquired by capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	208	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equipment acquired by capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of Related Party Convertible Promissory Note Into Common Stock [Member]
Promissory note converted to common stock
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of January 2019 Amended Notes to Common Stock [Member]
Promissory note converted to common stock
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-